DRIVIN G ROWTH - Dr. Reddy's
DRIVIN G ROWTH - Dr. Reddy's
DRIVIN G ROWTH - Dr. Reddy's
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
schedules to the balance sheet |<br />
(All amounts in Indian Rupees thousands, except share data)<br />
As at As at<br />
March 31, 2002 March 31, 2001<br />
b)Debentures and bonds<br />
Nil (previous year: 200) unsecured, redeemable, subordinated bonds of<br />
Rs. 5,000 each of Bank of Baroda (sold during the year)<br />
Nil (previous year: 460) unsecured, redeemable, subordinated<br />
floating interest rate bonds of Rs. 1,000 each of State Bank of India<br />
– 1,000<br />
(sold during the year) – 460<br />
II. Total unquoted investments 852,950 785,942<br />
Aggregate cost of investments (I + II) 857,551 790,543<br />
Less: Provision for decline, other than temporary, in the value of investments (218,119) (695)<br />
Total investments (net) 639,432 789,848<br />
Aggregate cost of quoted investments 4,601 4,601<br />
Aggregate cost of unquoted investments 852,950 785,942<br />
Market value of quoted investments 5,961 3,790<br />
NOTES:<br />
1. In respect of shares of State Bank of India and Reliance Industries Limited, the share certificates have been misplaced during<br />
transfer/lost in transit. The Company is taking necessary legal action at the appropriate courts.<br />
2. During the current year, the Company acquired an additional 4.9% of the equity share capital in Kunshan Rotam Reddy<br />
Pharmaceutical Co. Ltd. (Reddy Kunshan), which has resulted in the Company acquiring more than one-half of the voting power<br />
(51%). Consequent to this acquisition, Reddy Kunshan has become a subsidiary of the Company. For comparison purposes, the<br />
Company’s investment in Reddy Kunshan in the previous year has been reclassified. Equity shares held in Reddy Kunshan is not<br />
denominated in number of shares as per laws of China.<br />
schedule 7: inventories<br />
(All amounts in Indian Rupees thousands, except share data)<br />
As at As at<br />
March 31, 2002 March 31, 2001<br />
Stores and spares 188,263 195,445<br />
Raw-materials 597,928 378,823<br />
Work-in-process 514,779 508,789<br />
Finished goods 597,154 493,003<br />
schedule 8: sundry debtors<br />
(Unsecured)<br />
1,898,124 1,576,060<br />
Debts outstanding for a period exceeding six months<br />
Considered good 224,596 356,743<br />
Considered doubtful<br />
Other debts<br />
96,258 17,378<br />
Considered good 4,224,947 2,492,992<br />
4,545,801 2,867,113<br />
Less: Provision for doubtful debts 96,258 17,378<br />
4,449,543 2,849,735<br />
DR. REDDY’S LABORATORIES LTD. | FINANCIALS | ANNUAL REPORT 2001-2002<br />
115
Change language